These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 32828973

  • 1. Impacts of particle size on the cytotoxicity, cellular internalization, pharmacokinetics and biodistribution of betulinic acid nanosuspensions in combined chemotherapy.
    Wang R, Wang X, Jia X, Wang H, Li W, Li J.
    Int J Pharm; 2020 Oct 15; 588():119799. PubMed ID: 32828973
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
    Wang R, Yang M, Li G, Wang X, Zhang Z, Qiao H, Chen J, Chen Z, Cui X, Li J.
    Colloids Surf B Biointerfaces; 2019 Feb 01; 174():270-279. PubMed ID: 30469048
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, Mondhe DM, Panda AK, Gupta PN.
    Int J Pharm; 2017 Oct 05; 531(1):153-166. PubMed ID: 28823888
    [Abstract] [Full Text] [Related]

  • 4. Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.
    Li S, Zhang J, Fang Y, Yi J, Lu Z, Chen Y, Guo B.
    Drug Des Devel Ther; 2020 Oct 05; 14():243-256. PubMed ID: 32021108
    [Abstract] [Full Text] [Related]

  • 5. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution.
    Bi C, Miao XQ, Chow SF, Wu WJ, Yan R, Liao YH, Chow AH, Zheng Y.
    Nanomedicine; 2017 Apr 05; 13(3):943-953. PubMed ID: 27884638
    [Abstract] [Full Text] [Related]

  • 6. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
    Cai Y, Zheng Y, Gu J, Wang S, Wang N, Yang B, Zhang F, Wang D, Fu W, Wang Z.
    Cell Death Dis; 2018 May 25; 9(6):636. PubMed ID: 29802332
    [Abstract] [Full Text] [Related]

  • 7. Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer in vitro and in vivo.
    Wang G, Yang Y, Yi D, Yuan L, Yin PH, Ke X, Jun-Jie W, Tao MF.
    J Liposome Res; 2022 Sep 25; 32(3):250-264. PubMed ID: 34895013
    [Abstract] [Full Text] [Related]

  • 8. Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.
    Xu Y, Li J, Li QJ, Feng YL, Pan F.
    Biomed Pharmacother; 2017 Apr 25; 88():349-358. PubMed ID: 28119237
    [Abstract] [Full Text] [Related]

  • 9. Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells.
    Halder A, Jethwa M, Mukherjee P, Ghosh S, Das S, Helal Uddin ABM, Mukherjee A, Chatterji U, Roy P.
    Artif Cells Nanomed Biotechnol; 2020 Nov 17; 48(1):1362-1371. PubMed ID: 33284038
    [Abstract] [Full Text] [Related]

  • 10. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes.
    Liu Y, Gao D, Zhang X, Liu Z, Dai K, Ji B, Wang Q, Luo L.
    Mater Sci Eng C Mater Biol Appl; 2016 Jul 01; 64():124-132. PubMed ID: 27127036
    [Abstract] [Full Text] [Related]

  • 11. Research on the synthesis of nanoparticles of betulinic acid and their targeting antitumor activity.
    Chen X, Lu S, Gong F, Sui X, Liu T, Wang T.
    J Biomed Mater Res B Appl Biomater; 2022 Aug 01; 110(8):1789-1795. PubMed ID: 35179806
    [Abstract] [Full Text] [Related]

  • 12. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R, Wang C, Lu Y, Zhang C, Zhou H, Chen H, Li W.
    Int J Nanomedicine; 2020 Aug 01; 15():2733-2749. PubMed ID: 32368052
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
    Zeng A, Hua H, Liu L, Zhao J.
    Bioorg Med Chem; 2019 Jun 15; 27(12):2546-2552. PubMed ID: 30910472
    [Abstract] [Full Text] [Related]

  • 15. Betulinic Acid Nanogels: Rheological, Microstructural Characterization and Evaluation of their Anti-inflammatory Activity.
    Sosa-Gutierrez DS, Toro-Vazquez JF, Cano-Sarmiento C, Grube-Pagola P, Aparicio-Saguilan A, Torres-Palacios C, Acosta-Osorio AA, Garcia HS.
    Curr Drug Deliv; 2021 Jun 15; 18(2):212-223. PubMed ID: 32811400
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): part I. Albumin-bound betulinic acid nanoparticles (ABBns).
    Srivari Y, Chatterjee P.
    J Microencapsul; 2016 Dec 15; 33(8):689-701. PubMed ID: 27707051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy.
    Saneja A, Kumar R, Mintoo MJ, Dubey RD, Sangwan PL, Mondhe DM, Panda AK, Gupta PN.
    Mater Sci Eng C Mater Biol Appl; 2019 May 15; 98():764-771. PubMed ID: 30813082
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.